M.R. Prow

419 total citations
10 papers, 361 citations indexed

About

M.R. Prow is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, M.R. Prow has authored 10 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in M.R. Prow's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Receptor Mechanisms and Signaling (5 papers) and Pharmacology and Obesity Treatment (4 papers). M.R. Prow is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Receptor Mechanisms and Signaling (5 papers) and Pharmacology and Obesity Treatment (4 papers). M.R. Prow collaborates with scholars based in United Kingdom. M.R. Prow's co-authors include David J. Heal, W. R. Buckett, Sharon C. Cheetham, Jean Viggers, D.J. Heal, Keith F. Martin, Graham P. Luscombe, Jane Gosden, Helen L. Rowley and Christine Kettle and has published in prestigious journals such as British Journal of Pharmacology, International Journal of Obesity and Psychopharmacology.

In The Last Decade

M.R. Prow

9 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.R. Prow United Kingdom	8	195	138	91	74	63	10	361
Graham P. Luscombe United Kingdom	11	236 1.2×	256 1.9×	109 1.2×	79 1.1×	92 1.5×	19	516
Jean Viggers United Kingdom	7	161 0.8×	92 0.7×	111 1.2×	44 0.6×	24 0.4×	8	339
Dominic L. Li United States	7	205 1.1×	90 0.7×	123 1.4×	110 1.5×	22 0.3×	7	330
Mang‐Hung Tsai Taiwan	14	149 0.8×	115 0.8×	95 1.0×	83 1.1×	31 0.5×	22	484
Dawid Gawliński Poland	13	115 0.6×	119 0.9×	87 1.0×	94 1.3×	25 0.4×	25	402
Sotiria Bexis Ireland	13	188 1.0×	60 0.4×	118 1.3×	85 1.1×	41 0.7×	23	407
Nuria García‐Marchena Spain	15	182 0.9×	146 1.1×	95 1.0×	66 0.9×	34 0.5×	35	558
Pasqua Dipasquale Italy	8	183 0.9×	252 1.8×	90 1.0×	118 1.6×	38 0.6×	10	503
Michael H. Shannon United States	11	203 1.0×	48 0.3×	167 1.8×	173 2.3×	88 1.4×	16	527
Victoria Mendizábal Argentina	10	399 2.0×	322 2.3×	208 2.3×	112 1.5×	33 0.5×	17	631

Countries citing papers authored by M.R. Prow

Since Specialization

Citations

This map shows the geographic impact of M.R. Prow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.R. Prow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.R. Prow more than expected).

Fields of papers citing papers by M.R. Prow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.R. Prow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.R. Prow. The network helps show where M.R. Prow may publish in the future.

Co-authorship network of co-authors of M.R. Prow

This figure shows the co-authorship network connecting the top 25 collaborators of M.R. Prow. A scholar is included among the top collaborators of M.R. Prow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.R. Prow. M.R. Prow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Prow, M.R., et al.. (2001). Additive effects on rat brain 5HT release of combining phentermine with dexfenfluramine. International Journal of Obesity. 25(10). 1450–1453. 9 indexed citations

Rowley, Helen L., et al.. (2000). Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats. Synapse. 38(2). 167–176. 35 indexed citations

Kettle, Christine, Sharon C. Cheetham, Keith F. Martin, M.R. Prow, & D.J. Heal. (1999). The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortex. Neuropharmacology. 38(9). 1421–1430. 15 indexed citations

Heal, D.J., Sharon C. Cheetham, M.R. Prow, Keith F. Martin, & W. R. Buckett. (1998). A comparison of the effects on central 5‐HT function of sibutramine hydrochloride and other weight‐modifying agents. British Journal of Pharmacology. 125(2). 301–308. 87 indexed citations

Aspley, Sue, Susan Butler, M.R. Prow, Keith F. Martin, & D.J. Heal. (1997). D-fenfluramine-induced depletion of rat brain 5-HT is prevented by sibutramine or fluoxetine pretreatment. 1. 374. 1 indexed citations

Cheetham, Sharon C., et al.. (1996). [3H]Nisoxetine—A radioligand for noradrenaline reuptake sites: Correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments. Neuropharmacology. 35(1). 63–70. 108 indexed citations

Heal, David J., et al.. (1992). A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine. Psychopharmacology. 107(2-3). 303–309. 54 indexed citations

Heal, David J., M.R. Prow, & W. R. Buckett. (1991). Determination of the role of noradrenergic and 5‐hydroxytryptaminergic neurones in postsynaptic α₂‐adrenoceptor desensitization by desipramine and ECS. British Journal of Pharmacology. 103(4). 1865–1870. 14 indexed citations

Heal, David J., et al.. (1990). An investigation of the role of 5-hydroxytryptamine in the attenuation of presynapticα 2-adrenoceptor-mediated responses by antidepressant treatments. Psychopharmacology. 101(1). 100–106. 6 indexed citations

10.

Heal, David J., M.R. Prow, & W. R. Buckett. (1989). Measurement of 3‐methoxy‐4‐hydroxyphenylglycol (MHPG) in mouse brain by h.p.l.c. with electrochemical detection, as an index of noradrenaline utilisation and presynaptic α₂‐adrenoceptor function. British Journal of Pharmacology. 96(3). 547–556. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact